More Evidence Doesn’t Support Hydroxychloroquine For Patients With COVID-19

The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalised with pneumonia due to covid-19, finds a study from France published by The BMJ.

A randomised clinical trial from China also published today shows that hospitalised patients with mild to...